Hudson Bay Capital Management’s Enfusion, Inc. ENFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-81,601
Closed -$774K 1173
2024
Q3
$774K Sell
81,601
-90,108
-52% -$778K ﹤0.01% 700
2024
Q2
$1.46M Buy
171,709
+110,844
+182% +$1.01M 0.01% 565
2024
Q1
$563K Buy
+60,865
New +$536K ﹤0.01% 577
2023
Q4
Sell
-460,084
Closed -$4.13M 930
2023
Q3
$4.13M Buy
460,084
+105,236
+30% +$999K 0.03% 339
2023
Q2
$3.98M Buy
+354,848
New +$3.15M 0.03% 364

Other funds holding ENFN

Hudson Bay Capital Management's ENFN Position: Q4 2024 in Review

Hudson Bay Capital Management sold out of Enfusion, Inc. (ENFN) in Q4 2024, closing a stake of 81,601 shares — an estimated $774K sold.

Hudson Bay Capital Management first reported a position in ENFN in Q2 2023 and held it in 5 quarters. The position peaked at $4.13M in Q3 2023. 132 funds tracked by Wall St. Rank hold ENFN as of Q4 2024.

  • Hudson Bay Capital Management reported no remaining Enfusion, Inc. position as of Q4 2024 after selling out during the quarter.
  • Hudson Bay Capital Management sold 81,601 Enfusion, Inc. shares in Q4 2024, an estimated $774K.
  • Hudson Bay Capital Management first reported a position in Enfusion, Inc. in Q2 2023 and held it in 5 quarters.
  • Hudson Bay Capital Management's Enfusion, Inc. position peaked at $4.13M in Q3 2023.
  • 132 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q4 2024.

Based on Hudson Bay Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.